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Abstract
Numerous epidemiological studies have consistently demonstrated that individuals who eat more fruits and vege-
tables (which are rich in carotenoids) and who have higher serum β-carotene levels have a lower risk of cancer,
especially lung cancer. However, two human intervention trials conducted in Finland and in the United States have
reported contrasting results with high doses of β-carotene supplementation increasing the risk of lung cancer
among smokers. The failure of these trials to demonstrate actual efficacy has resulted in the initiation of animal
studies to reproduce the findings of these two studies and to elucidate the mechanisms responsible for the harm-
ful or protective effects of carotenoids in lung carcinogenesis. Although these studies have been limited by a lack of
animal models that appropriately represent human lung cancer induced by cigarette smoke, ferrets and A/J mice are
currently the most widely used models for these types of studies. There are several proposed mechanisms for the
protective effects of carotenoids on cigarette smoke–induced lung carcinogenesis, and these include antioxidant/
prooxidant effects, modulation of retinoic acid signaling pathway and metabolism, induction of cytochrome P450,
and molecular signaling involved in cell proliferation and/or apoptosis. The technical challenges associated with
animal models include strain-specific and diet-specific effects, differences in the absorption and distribution of carot-
enoids, and differences in the interactions of carotenoids with other antioxidants. Despite the problems associated
with extrapolating from animal models to humans, the understanding and development of various animal models
may provide useful information regarding the protective effects of carotenoids against lung carcinogenesis.
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Introduction
Lung cancer is the most common cancer worldwide and has remained
the leading cause of cancer death in the United States for the past
10 years [1]. A large body of observational, epidemiological studies
have consistently demonstrated that consumption of carotenoids in-
cluding β-carotene, lycopene, and β-cryptoxanthin and their higher
serum levels is associated with a lower risk of cancer, most notably lung
cancer [2–6]. As a result, a number of studies involving various animal
models have been performed to investigate the effects of carotenoids
on lung carcinogenesis and to establish biologic plausibility (Table 1).
However, there is no adequate animal model available for the evalua-
tion of the role of carotenoids in human lung carcinogenesis result-
ing from tobacco smoke. To date, previous studies have reported the
different effects of carotenoids on lung carcinogenesis owing to various
experimental conditions, including the dose of the carotenoid admin-
istered, the duration of the studies conducted, and the differences in
the metabolism of carotenoids by different animals. Therefore, it is
necessary to thoroughly examine the literatures published to date to
develop and use appropriate animal models in future studies. The goals
of this review were to summarize the animal models currently available
and to identify the major hypotheses that have been identified for the
effects of carotenoids on lung carcinogenesis.
Lung Cancer and Cigarette Smoke
Lung cancer is believed to arise after a series of progressive pathologic
changes that occur in preneoplastic or precancerous lesions present in
the respiratory mucosa. The four major histologic types of lung can-
cer include squamous cell carcinoma, adenocarcinoma, small cell
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carcinoma, and large cell carcinoma [7]. However, there are also sev-
eral preneoplastic lesions that have been identified, which include
squamous metaplasia, dysplasia, and atypical adenomatous hyper-
plasia [8]. Although hyperplasia and squamous metaplasia are consid-
ered reactive and reversible changes, dysplasia and carcinoma in situ
are the changes most frequently associated with the development of
squamous cell carcinoma [7]. For adenocarcinoma, changes can in-
clude atypical adenomatous hyperplasia in peripheral airway cells [9].
Although other agents, including occupational carcinogens, can
contribute to the incidence of lung cancer, cigarette smoking and
exposure to second-hand smoke are the two main risk factors that
have been associated with the development of lung cancer. A total
of 90% of lung cancer cases are associated with exposure to tobacco
smoke [10]. Animal studies have identified more than 62 carcinogens
present in cigarette smoke, and 15 of these compounds have been
confirmed to be carcinogenic in humans [11,12]. Particulate phase con-
stituents of cigarette smoke include polycyclic aromatic hydrocarbons,
which include well-known components such as benzo[a]pyrene (BaP)
and tobacco-specific nitrosamines such as 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) [13]. NNK is a potent and selective lung
carcinogen in various species, independent of the route of administration.
In addition to the carcinogenic compounds mentioned previously,
cigarette smoke contains a variety of free radicals and reactive oxygen
species, which have been shown to cause oxidative damage to various
tissues of the human body [14]. Reactive oxygen species from cigarette
smoke severely depletes both extracellular and intracellular antioxidants
in humans. The resulting DNA damage and antioxidant depletion
induced by cigarette smoke is considered to be a critical aspect of car-
cinogenesis that affects the lungs, esophagus, kidneys, pancreas, and
cervix [15].
Because there are few known effective therapies available for
the treatment of lung cancer, chemoprevention by dietary compo-
nents, including carotenoids, could be an excellent way to reduce this
devastating disease.
Carotenoids and Lung Carcinogenesis
Carotenoids are a class of lipophilic compounds with polyisoprenoid
structures. There are six major types of carotenoids, and these include
α-carotene, β-carotene, lycopene, β-cryptoxanthin, lutein, and zeaxan-
thin [16]. They are routinely detected in human plasma and tissue,
and α-carotene, β-carotene, and β-cryptoxanthin are provitamin A
carotenoids that can be cleaved to form vitamin A [17,18]. Evidence
from a number of observational, epidemiological studies has consis-
tently demonstrated an inverse association between the incidence of
lung cancer and a high consumption of fruits and vegetables (which
are rich in carotenoids). In particular, people with higher serum levels
of β-carotene, lycopene, and cryptoxanthin have been associated with a
lower risk of lung cancer [2–6]. In addition, carotenoids 1) function
as antioxidants [19,20], 2) are precursors of retinoic acid (RA) [21,22],
3) enhance gap junction communication [23–25], 4) function as
immune enhancers [26–28], 5) inhibit cell proliferation [29], 6) in-
duce cell apoptosis [29,30], 7) suppress insulin-like growth factor 1
(IGF-1)–stimulated cell proliferation by inducing insulin-like growth
factor-binding protein (IGFBP) [31], and 8) induce carcinogen-
metabolizing enzymes [32]. However, in two intervention trials, the
Alpha-Tocopherol, Beta-carotene Cancer Prevention Trial in Finland
[33] and the β-Carotene and Retinol Efficacy Trial in the United
States [34–36], an increased risk of lung cancer was associated with
smokers and asbestos workers who consumed supplements containing
β-carotene. In contrast, the Physicians’ Health Study reported no
adverse effects associated with β-carotene supplementation for lung
cancer risk in either smokers or nonsmokers [37]. On the basis of
the contrasting results obtained from these trials, attempts have been
made to develop appropriate animal models to explain the reasons
and mechanism(s) of the discrepancies. However, a limited number
of animal models are available to address the effectiveness of dietary
chemopreventive agents against smoke-induced lung cancer, and these
models are associated with various advantages and disadvantages.
Animal Models of Carotenoids Research in
Lung Cancer
Ferret Model Studies
Data from various animal models have demonstrated that caroten-
oids are associated with a protective effect during lung carcinogenesis.
A ferret (Mustela putorious furo) model has been extensively used for
studies of lung cancer and stomach cancer owing to the physiological
similarities it shares with humans [38–41]. Specifically, ferrets and hu-
mans have similar carotenoids absorption [42,43], metabolism [40,44–
46], tissue distribution and levels [39,40,47], biologic functions
[39,40,47], and regulation of genes, including RA receptor β (RARβ)
and IGFBP-3 [39,40]. In addition, the ferret has been used as a model
for studies in inhalation toxicology owing to similarities in the lung
architecture of ferret and human, a fact indicating that ferrets provide
advantages over other animal models (e.g., mice, rats, or hamsters) in
studies of lung carcinogenesis induced by cigarette smoke.
Daily exposure to cigarette smoke (equivalent to humans who smoke
1.5 packs per day) by ferrets for 2 to 6 months resulted in proliferative
changes and squamous metaplasia in the lungs [39,47]. Further, the
combination of NNK with smoke exposure for 6 months successfully
induced various lung preneoplastic lesions and neoplasia in ferrets
[8]. Importantly, the morphologic characteristics of these tumors,
including squamous cell carcinoma and adenocarcinoma as well as
preneoplastic lesions in ferret lungs, closely resemble those found in
humans, indicating that this animal model is appropriate for the study
of human lung epithelial malignancies. Because most nutrients block or
delay the progression of the early phase of tumor rather than the late
phase, the findings of preneoplastic lesions in this ferret model may
Table 1. Animal Model Studies in Carotenoids and Lung Carcinogenesis.
Model Carotenoids Investigators Reference
Ferret β-Carotene Kim et al. Carcinogenesis [38]
Ferret β-Carotene Wang et al. J Natl Cancer Inst [40]
Ferret β-Carotene van Helden et al. Carcinogenesis [51]
Ferret β-Carotene Liu et al. Carcinogenesis [47]
Ferret β-Carotene Fuster et al. J Nutr Biochem [53]
Ferret Lycopene Liu et al. Cancer Res [39]
Ferret β-Cryptoxanthin Liu et al. Cancer Prev Res [54]
Mouse α-Carotene Tsuda et al. IARC Sci Publ [59]
Mouse β-Carotene or lycopene Huang et al. J Nutr [66]
Mouse Lycopene Guttenplan et al. Cancer Lett [74]
Mouse Lycopene Kim et al. Cancer Lett [137]
Mouse (A/J) β-Carotene Goralczyk Nutr Cancer [55]
Mouse (A/J) Apo-10′-lycopenoic acid Lian et al. Carcinogenesis [72]
Mouse (A/J) Lycopene Hecht et al. Cancer Lett [73]
Mouse (A/J) 9-cis-RA Mernitz et al. Cancer Lett [75]
Mouse (A/J) β-Cryptoxanthin Kohno et al. Cancer Lett [77]
Rat β-Carotene Paolini et al. Nature [87]
Hamster β-Carotene Furukawa et al. Jpn J Cancer Res [90]
Hamster β-Carotene Al-Wadei and Schuller Eur J Cancer [91]
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be important in terms of cigarette smoke–related chemoprevention
studies. A novel observation associated with the ferret model has been
the development of a mixed cell type such as adenosquamous carci-
noma with both glandular and squamous differentiation. This con-
dition is similar to that of adenosquamous carcinomas that have been
detected in humans [48,49].
Humans can absorb significant amounts of intact carotenoids (e.g.,
β-carotene and lycopene) and accumulate very high concentrations
of carotenoids in the liver and peripheral tissues, whereas most animal
species (e.g., mice, rats, guinea pigs, rabbits, and sheep) absorb virtually
no carotenoids in their intact form, except at high doses [42]. The
absorption of intact carotenoids and absorption efficiency between
ferrets and humans are quite similar. Ferrets fed β-carotene at 4 or
20 mg/kg of body weight (BW) achieved high serum concentrations
(15 and 41 μg/dl) and appreciable levels in the liver and adipose tissue,
whereas rats fed the same levels of β-carotene achieved minimal serum
levels with no detectable β-carotene in either the liver or the adipose
tissue [50].
Wang et al. [40] reproduced the harmful effects of large doses of
β-carotene shown in human intervention studies using ferrets. The
study demonstrated that ferrets exposed to smoke and supplemented
with a high dose of β-carotene (equivalent to 30 mg/d in humans as
given in the β-Carotene and Retinol Efficacy Trial) for 6 months de-
veloped lung squamous metaplasia compared with controls. Further,
smoke-exposed and high-dose β-carotene–supplemented animals
showed lower RA levels in their lungs [40]. However, when ferrets
received 0.8 mg of β-carotene/kg per day (equivalent to ∼10 mg/d in
humans) by oral gavage, the malondialdehyde-derived DNA adduct,
3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-α]purin-10
(3H )-one deoxyguanosine (M1dG), induced by BaP was inhib-
ited. In contrast, the levels of 8-oxo7,8-dihydro-2′-deoxyguanosine
(8-oxo-dG) were not affected [51]. This is probably due to the
increased base excision repair capacity in this model. Unlike in the
in vivo experiment, the physiological dose of β-carotene (5 μM) has
been shown to enhance levels of 8-oxo-dG in A549 and BEAS-2B
lung epithelial cells while inhibiting M1dG. This difference in the
effects of β-carotene on M1dG adducts and 8-oxo-dG suggested a
role for β-carotene as a prooxidant, or an antioxidant, depending
on the type of radicals involved.
In a study of ferrets that received combined physiological doses of
β-carotene (0.85 mg/kg BW per day), α-tocopherol (22 mg/kg BW
per day), and ascorbic acid (3 mg/kg BW per day) for 6 months, the
ferrets were found to be protected from NNK-induced lung carcino-
genesis after long-term exposure to smoke [38]. In addition, plasma
β-carotene concentrations were not reduced during this treatment
regimen, indicating that β-carotene degradation may be prevented in
the presence of α-tocopherol and ascorbic acid. Furthermore, lower
levels of RA present in the lungs of the ferrets exposed to smoke
and treated with NNK were completely restored to normal levels after
administration of the combined supplementation [40,52]. This may
be due to the enhanced central cleavage of β-carotene or to the in-
hibition of eccentric cleavage of β-carotene, resulting in an increase
in RA production or in a decrease in RA catabolism, respectively.
The presence of certain antioxidants was previously shown by Fuster
et al. [53] to be important in determining the cancer-protective
or cancer-promoting effects of β-carotene. In their study, ferrets
were treated with two different concentrations of β-carotene (0.8 vs
3.2 mg/kg BW per day) as a water-soluble formulation containing
DL-α-tocopherol and ascorbyl palmitate for 6 months. BaP, a primary
lung carcinogen from tobacco smoke, was also administered orally
in the presence or absence of β-carotene. When β-carotene was ad-
ministered in combination with DL-α-tocopherol and ascorbyl palmi-
tate, levels of jun protein and those of cyclin D1 messenger RNA
(mRNA) were reestablished in the lungs of BaP-treated animals. More-
over, the prooxidant effects associated with a high dose of β-carotene
were abolished.
Another carotenoid, lycopene, has shown anticancer effects against
lung cancer. Lycopene supplementation at a low dose (1.1 mg/kg BW
per day) and a high dose (4.3 mg/kg BW per day) for 9 weeks showed
significantly higher plasma levels of IGFBP-3 and lower levels of IGF-I/
IGFBP-3 in smoke-exposed ferrets than in those exposed to smoke
alone [39]. Recently, the chemopreventive effects of β-cryptoxanthin
against lung carcinogenesis have been demonstrated in a ferret model
[54]. For example, both a low dose of β-cryptoxanthin (equivalent to
105 g/d in humans) and a high dose of β-cryptoxanthin (equivalent
to 525 g/d in humans) were associated with anti-inflammatory and
anticancer effects, including a reduction in levels of proinflammatory
cytokines, tumor necrosis factor α, and transcription factors (nuclear
factor κB and activator protein 1 [AP-1]) and 8-oxo-dG. The inci-
dence of squamous metaplasia was also reduced in ferrets exposed to
cigarette smoke. On the basis of these results, Liu et al. [54] proposed
that the anticancer effects of β-cryptoxanthin may not be due to its
provitamin A activity.
Despite the number of advantages of ferrets, there are several dis-
advantages associated with the ferret model. Vitamin A transport and
metabolism in ferrets differ those in humans, and the cleavage rate of
β-carotene is low in ferrets [55]. Additional disadvantages include the
limited number of partial-length or full-length complementary DNA
available from GenBank and the incomplete sequencing of the ferret
genome [56]. Moreover, ferret-specific primers, probes, and antibodies
are not commercially available for this model, which limits the in-
vestigation of molecular and immunologic mechanisms involved in
carcinogenesis and further limits the usefulness of the ferret model.
Mouse Model Studies
Mouse model, particularly, the A/J mice model is the most com-
monly used animal model for lung carcinogenesis. Mice do not require
much space and are inexpensive to perform experiments with compared
to larger animals. Furthermore, genetic information for mice is widely
available, along with mouse-specific primers and antibodies that are
commercially available. As a result, there have been many advances
in the development of genetically modified animal models, as well as
xenograft tumor models. In combination, these models have enhanced
our understanding of the molecular mechanisms related to cancer ini-
tiation and promotion. However, the use of rodent models for studies
of tobacco smoke inhalation is still associated with many difficulties
because rodents are obligatory nose breathers, and their complex nasal
structures differ from those of humans [13]. In addition, it is known
that most rodents do not accumulate carotenoids owing to the poor
absorption, bioavailability, and conversion to vitamin A of carotenoids
in this model [57,58]. Therefore, further development of murine mod-
els based on the purpose of the study to be conducted is still necessary.
Carcinogen-Induced Mouse Models. Two types of carotenoids
were evaluated in a study of male and female B6C3F1 mice that
were treated with N ,N -diethylnitrosamine (DEN) and N -methyl-
N -nitrosourea while receiving α-carotene (0.4 mg per mouse) and
β-carotene (0.4 mg per mouse) three times a week by gavage for
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20 weeks. After an analysis of the lung tissues, an association between
administration of α-carotene and a reduction in both hyperplasia and
adenomas was observed only in male mice [59].
In a second study, skin painting with N -nitroso-tri-chloroethylurea
for 8 months was shown to induce squamous cell carcinoma in the
lungs of various strains of mice [60]. However, the specificity of the
lung tumors induced by these carcinogens and the application of this
model to cigarette smoke–related lung cancer prevention require
further investigation.
Xenograft Mouse Models. Xenograft mouse models have been
used to investigate the relationship between carotenoids and RA,
and various cancers such as prostate cancer, gliomas, and neuro-
blastoma [61,62]. A549 lung cancer cells have been widely used for
lung cancer xenograft models to study the effect of chemotherapeutic
drugs on lung carcinogenesis [63,64]. However, few studies have
demonstrated the effects of nutrients on human lung carcinogenesis
using xenograft animal models. Recently, Lu et al. [65] reported the
chemopreventive effects to be associated with a γ-tocopherol-rich
mixture of tocopherols in carcinogen-induced A/J mice and H1299
human lung cancer cell xenograft tumors. In another model, supple-
ments of lycopene or β-carotene were administered two times per week
for 12 weeks to athymic nude mice that had received tail vein injections
of SK-Hep-1 cells [66]. This treatment regimen was associated with a
decrease in tumor numbers and a decrease in the expression of matrix
metalloproteinase 9 and vascular endothelial growth factor. More-
over, Schleicher et al. [67] demonstrated that retinoids (2-hydroxyethyl
retinimade, N -[4-hydroxy-phenyl] all-trans-retinamide, and 13-cis-RA)
have an antimetastatic potential in a malignant hamster melanoma cell
line (HM1-F5) that was injected into athymic mice.
A/J Mice. The strain A mouse lung tumor model, particularly
carcinogen-treated A/J mice, was the first murine model of lung can-
cer, and it has been extensively used to evaluate the chemopreventive
efficacy of various carotenoids against lung carcinogenesis [68–70].
However, although A/J mice develop similar adenocarcinomas as those
seen in humans [13], this mouse model frequently develops sponta-
neous Ki-ras mutations, and only lung adenoma and adenocarcinoma
are induced by NNK in the presence or absence of cigarette smoke,
respectively [68,69]. Unfortunately, premalignant lesions and squa-
mous cell carcinomas do not usually develop in these mice in contrast
with human malignancies.
In the study by Goralczyk et al. [71], which investigated the effect
of β-carotene on NNK-induced lung carcinogenesis in A/J mice,
animals were fed various doses of β-carotene as part of an enhanced
diet containing 0.25% sodium cholate and 5% corn oil with the
purpose of increasing β-carotene absorption. Plasma and lung con-
centrations of β-carotene reached similar levels to those detected in
humans, and tumor multiplicity, the functional end point, was not
significantly affected by β-carotene supplementation regardless of
dose or time point of treatment in either NNK-treated or control
animals. Moreover, β-carotene was not able to completely reverse
the down-regulation of RARβ induced by NNK in these mice.
The metabolite of lycopene, apo-10′-lycopenoic acid, suppressed
NNK-induced lung tumorigenesis in A/J mice [72]. The mice were
given 10-, 40-, or 120-mg/kg diet of apo-10′-lycopenoic acid for
2 weeks before lung tumors were induced by the injection of NNK.
After 16 weeks on the experimental diets, there were dose-dependent
increases in plasma levels of apo-10′-lycopenoic acid and significant
dose-dependent decreases in tumor multiplicity in the treated animals.
However, tumor incidence was not affected by this treatment regimen.
In contrast, when A/J mice received dietary lycopene-enriched tomato
oleoresin for 8 weeks, whereas lung tumors were induced by tobacco
smoke carcinogens, BaP and NNK, no effect on lung tumor multiplic-
ity was observed [73]. Furthermore, when lycopene was supplemen-
ted, BaP-induced mutagenesis was found to be enhanced in both
lung and colon tissues but slightly decreased in prostate [74]. In com-
bination, these data suggest that lycopene or lycopene metabolites may
have the potential to enhance lung carcinogenesis similar to β-carotene
and its metabolites, and this effect may be organ-specific.
In A/J mice that received 9-cis-RA for 4 months, NNK-induced
lung tumor multiplicity was significantly lowered and RARβ expression
was upregulated [75]. Furthermore, when 9-cis-RA was administered
in combinationwith 1α,25-dihydroxyvitaminD3 (1,25D), this regimen
was observed to effectively prevent the toxicity associated with 1,25D
treatment, without compromising the chemopreventive efficacy of
1,25D during lung carcinogenesis [76]. In another study of male A/J
mice, consumption of a citrus juice rich in β-cryptoxanthine (3.9 mg/
100 g of juice) and hesperidin (100 mg/100 g of juice) for 21 weeks
resulted in a 29% reduction in the incidence of NNK-induced lung
tumors [77]. Moreover, the proliferating cell nuclear antigen–positive
index of the lung tumors that developed was reduced in the citrus
juice–treated group, suggesting that β-cryptoxanthine can mediate
chemopreventive effects against lung carcinogenesis.
Transgenic Mouse Models. Using transgenic technology to express
oncogenes or to repress tumor suppressor genes, murine transgenic
models for lung carcinogenesis have been developed to study effective
therapeutic interventions for lung cancer. In particular, because p53
mutations play an important role in cigarette smoke–induced lung
carcinogenesis, NNK or BaP-induced lung tumor p53 mutant mouse
model on A/J F1 background was developed [78]. In addition, tar-
geted expression of genes in nonciliated Clara airway epithelial cells
was produced using a Clara cell secretory protein (CCSP/CC10) pro-
moter driving expression of SV40 T antigen (TAG) or other genes [79].
Although this TAG mice model is one of the most aggressive lung-
directed models developed to date, these mice do not replicate the
preneopalstic lesions and metastatic characteristics of lung cancer
observed in humans.
A few transgenic animal models have been developed, which dem-
onstrated the preventive effect of retinoids. For example, in the C3(1)
SV40 large T/t-antigen (Tag) transgenic mouse, 9-cis-RA was found to
inhibit mammary tumorigenicity [80]. In addition, a synthetic retinoid,
N -(4-hydroxyphenyl)retinamide (4-HPR), was found to delay T-cell
lymphoma development in transgenic mice overexpressing the pim-1
oncogene that were treated with N -ethyl-N -nitrosourea [81]. Re-
cently, mouse knockout models of β-carotene 15,15′-monooxygenase 1
(Bcmo1−/−) mice [82] and carotene-9′10′-monooxygenase II (CMO-
II−/−) mice [83] were developed. These models have been used to study
carotenoid metabolism and the effects of β-carotene on hormone
synthesis. Moreover, the continued use of these models in studies of
various cancers could provide further evidence regarding the role of
carotenoids in mediating carcinogenesis.
Rat Model Studies
Rat models have frequently been used to investigate the absorp-
tion, uptake, and tissue distribution of carotenoids. For example,
F344 rats have been used to investigate the metabolism of lycopene,
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or lycopene metabolites, and their influence on prostate cancer [84–
86]. In lung carcinogenesis studies, F344 rats are also commonly
used to evaluate dietary interventions for cigarette smoke–induced
lung lesions. On the basis of the substantial amounts of NNK con-
tained in cigarette smoke, the total dose that is received after a lifetime
of smoking was surprisingly close to the lowest total dose shown to
induce tumors in these animals [68]. Furthermore, tumors can be
induced by NNK in the lungs, nasal cavities, and livers of F344 rats
after subcutaneous (s.c.) injections [68]. However, there is limited
evidence regarding the chemopreventive effects of carotenoids on lung
cancer in F344 rats. Therefore, the development of a reliable F344
rat model would be beneficial to understand dietary interventions,
particularly in the study of carotenoids and lung carcinogenesis.
To understand the inconsistency of observational, epidemiological
studies regarding the harmful effects of pharmacological doses of
β-carotene, Paolini et al. [87] demonstrated a significant increase in
the levels of several cytochrome (CYP) enzymes, including CYP
1A1, in the lungs of male Sprague-Dawley (SD) rats that had been
supplemented with a very high dose of β-carotene (500 mg/kg BW).
However, it is not clear whether this increase in enzyme levels was
directly related to the high dose of β-carotene administered or was
indirectly related to its metabolites that were generated. Additional
variables that can be considered include diet composition. For example,
the percentage of fat in the diet can affect serum concentrations
of lipid-soluble carotenoids. Correspondingly, serum levels of lycopene
have been shown to be almost two-fold higher in F344 rats that were
fed lycopene-rich tomato carotenoid oleoresin at 500 ppm in a diet for
10 weeks [88] compared with the levels of serum lycopene in SD rats
that were fed the same amount of lycopene for 18 weeks [89]. These
differences in serum levels of lycopene could be due to the amount of
fat in each diet (e.g., 4% corn oil in the grain-based diet vs 5% corn
oil in the AIN-76A diet used, respectively), the strain-specific differ-
ences in terms of carotenoids absorption, and/or the presence of other
carotenoids [89].
Other Animal Model Studies
Syrian golden hamsters have been used to study lung cancer induced
by carcinogens such as BaP [10], N -dibutylnitrosamine [10], DEN
[90], and NNK [68,91]. In humans, the most predominant histologic
type of lung cancer is that of small airway-derived pulmonary adeno-
carcinomas (PACs), which are thought to arise from epithelial cells
composed of Clara cells in the small airways in the lung periphery
[92]. In hamsters, the trachea and stem bronchi are coated by a pseudo-
stratified respiratory epithelium found in the large airway of humans,
and these consist of basal cells and ciliated cells [10]. This is in con-
trast with the respiratory epithelia of the mice, which are composed
of nonciliated Clara cells that are restricted to small airways, similar
to bronchioles in humans. Furthermore, spontaneous and NNK-
induced lung tumors in mice are derived from alveolar type II cells
[93], whereas these lung tumors in hamsters are derived from small
airway epithelia, similar to that of PACs in humans. Tumor expression
in hamsters has also been shown to involve activating point mutations
in K-ras [94] and overexpression of the epidermal growth factor re-
ceptor [95], similar to human tumors. Moreover, retinoid-induced
inhibition of cell proliferation involving cAMP-dependent inhibition
of extracellular signal–regulated kinase 1/2 phosphoryaltion in human
large airway epithelial cells has been observed in hamster tumor model
[96]. Therefore, because of the similarities in the features of PAC
exhibited by humans and hamsters, NNK-induced PAC in Syrian
golden hamsters has been used as a model of human small airway-
derived PAC [97].
In one experiment, in which two groups of Syrian golden hamsters
were treated with either BaP or unfiltered research cigarette smoke and
one group of European hamsters was treated subcutaneously with
N -dibutylnitrosamine, all developed atypical cilia in their tracheae and
bronchi [10]. In another study, Syrian golden hamsters were treated
with s.c. injections or oral swabs of NNK, and tumors were induced in
the lungs, trachea, and nasal cavities of this model [68,98].
Hamster models have also been used to evaluate the protective ef-
fects of β-carotene on upper respiratory tumorigenesis (e.g., trachea
and larynx) induced by exposure to smoke and DEN [90]. A total of
120 male Syrian hamsters received a single s.c. injection of 100 mg/kg
BW DEN and were then exposed to smoke from nonfiltered cigarettes
and supplemented with various doses of β-carotene (0%, 0.005%,
0.05%, or 0.25%) for 12 weeks. In this study, the incidence and
multiplicity of hyperplasia were found to be dose dependent in relation
to the amount of β-carotene administered.
Recently, Al Wadei and Schuller [91] demonstrated that β-carotene
enhanced the development of NNK-induced PAC in Syrian golden
hamsters. The development of PAC in the small airway epithelial cells
of the hamsters was induced with NNK treatments (2.5 mg/100 g BW
three times a week for 10 weeks). One week after the last NNK injec-
tion, β-carotene injections (5 μM β-carotene in 0.2 ml of sesame oil
administered s.c. twice a week) were given for 1.5 years. This treat-
ment group was then found to be associated with increased lung tumor
multiplicity, tumor size, blood cell cAMP, and increased levels of
cAMP response element binding and extracellular signal–regulated ki-
nase 1/2 phosphorylation in lung tumor samples. In combination, these
results suggest that lung tumorigenicity was enhanced by β-carotene
through increased cAMP signaling.
As a species similar to ferret (Mustela putorius furo), lung carcinoma
was developed in minks (Mustala vison) [99]. In this model, adminis-
tration of nitrosonornicotine (11.9 mM/mink) or NNK (6.3 mM/
mink) for 19 months induced the development of lung adenocarci-
noma. Work is still ongoing to evaluate the effects of carotenoids on
lung carcinogenesis in this model.
Levels of Carotenoids in Plasma and Lung
Tissues Vary between Supplementation
Studies Performed in Various Animal Models
Several studies have reported plasma and lung concentrations of carot-
enoids obtained from supplementation studies performed in various
animal models, including humans (Table 2). However, it is difficult
to interpret the effects of carotenoids from these studies because of
the differences in the various supplementation methods and the dura-
tion of carotenoids administered. In addition, there are differences in
the metabolism and absorption of carotenoids in animal models, along
with differences in the units used for carotenoids concentrations de-
tected in plasma and tissue. However, a consistent result is that plasma
and lung tissue concentrations of carotenoids significantly increase in
most animal models supplemented with carotenoids, particularly
β-carotene and lycopene.
In humans, β-carotene (20 mg/d) was supplemented for 5 to
8 years in the Alpha-Tocopherol, Beta-carotene Cancer Prevention
Trial, and this dose is 10-fold higher than the average intake of
β-carotene in a typical American diet, which is approximately 2 mg/d.
When plasma levels of β-carotene were assayed, an approximate 18-fold
increase in levels of β-carotene was detected [16]. Similarly, when
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β-carotene (2.4 mg/kg BW, approximately 30 mg/d) was administered
to ferrets for 6 months, the plasma concentration of β-carotene was
increased approximately 20-fold [40]. In another study, when dietary
lycopene (30 mg/d) was supplemented for 3 weeks in humans, the
plasma concentration of lycopene was 1300 nM [100]. However,
human epidemiological studies have identified a reference range for
plasma lycopene to be 290 to 350 nM, and the level of plasma lyco-
pene detected in the ferret model administered lycopene supplement
(equivalent to 15 mg/d in humans) was 226 nM [39,101,102]. Taken
together, these studies indicated similarities of absorption and accumu-
lation of these carotenoids between ferrets and humans.
However, cigarette smoke exposure inhibited the supplementation-
induced elevation of plasma and lung tissue level of β-carotene or
lycopene [39,40]. These results are consistent with many epidemi-
ological studies, which reported that smokers had lower plasma/serum
concentrations of β-carotene than nonsmokers do [103,104]. Further-
more, it has been hypothesized that these results represent a smoke-
induced oxidization of β-carotene that generates a number of transient
oxidative metabolites, as well as smoke-induced isomerization and
degradation of lycopene.
Whereas rodent models have been widely used in carotenoids re-
search, the suitability of these models has been questioned based on
the poor absorption of carotenoids exhibited by these models relative
to that of humans [85,105]. For example, Huang et al. [106] per-
formed a study where lycopene supplements (20 mg/kg BW every
2 days) were administered to various rodent models (F344 rats, nude
mice, and BALB/c mice) for 10 days, and then plasma levels of
lycopene were compared. Of these three strains, nude mice (224 ±
51 nM) exhibited the highest levels of lycopene followed by BALB/c
mice (198 ± 52 nM) and F344 rats (139 ± 41 nM). It is possible that
the differences in lycopene plasma concentrations were due to the dif-
ferences in the plasma lipoprotein profiles of these rodent species. How-
ever, the results from this comparison did indicate that nude mice are
more appropriate than BALB/c mice or F344 rats for the investigation
of in vivo effects of lycopene in humans.
Possible Mechanisms for the Effects
of Carotenoids on Smoke-Induced
Lung Carcinogenesis
There are several hypotheses that have been developed to explain the
protection against lung carcinogenesis provided by carotenoids, and
these are outlined in Figure 1. These hypotheses involved 1) anti-
oxidant and prooxidant effects, 2) the effects of carotenoids on levels
of RA and its signaling, 3) induction of CYP enzymes, 4) and signal-
ing pathways involved in apoptosis, proliferation, and differentiation.
Antioxidant and Prooxidant Effects of Carotenoids
Antioxidant effects mediated by carotenoids have been well char-
acterized and have been shown to prevent oxidative damage [107].
Cigarette smoke contains free radicals as well as carcinogens. There-
fore, smokers develop higher levels of free radicals, higher levels of
lipid peroxidation products, and lower levels of antioxidants in their
plasma and lungs compared with nonsmokers [108–110]. Palozza
et al. [111] have demonstrated the antioxidant effect of β-carotene
by inhibiting cigarette smoke condensate (tar)–induced lipid peroxida-
tion. Antioxidant properties of many carotenoids have been believed
to play important roles in anticarcinogenic actions. Of the carotenoids
identified to date, lycopene has been associated with the most powerful
antioxidant activity [112]. Numerous in vivo studies using tomatoes,
or tomato products, have demonstrated that the antioxidant proper-
ties of lycopene can mediate a decrease in DNA damage, low-density
lipoprotein oxidation, and lipid peroxidation [113–116]. It has also
been proposed that carotenoids have prooxidant properties based on
their interactions with free radicals present in cigarette smoke, or
carotenoids oxygenated products produced by high consumption of
carotenoids, particularly in the oxidative environment of a smoker’s
lung [117,118]. Correspondingly, the formation of β-apo-carotenals
from all-trans-β-carotenes was higher when lung extracts from ferrets
exposed to cigarette smoke were compared with lung extracts of ferrets
that were not exposed to cigarette smoke. Further, these oxidative
metabolites might lower the levels of RA in lungs of these animals.
Some observations support the hypothesis that a complex network
of intracellular antioxidants has a critical role in preventing the oxida-
tive damage induced by cigarette smoke. Previously, in vitro studies
have detected strong interactions between β-carotene, α-tocopherol,
and ascorbic acid that result in the protection from oxidative damage.
Furthermore, these antioxidants have been shown to regenerate each
other from their radical cation and enhance their antioxidant efficiency
mutually [119]. In a ferret model, Kim et al. [52] also found that the
combination of the three antioxidants mediates a potential chemo-
preventive effect against smoke-induced lymphocyte DNA damage.
In combination, these observations support the hypothesis that combi-
nations of antioxidants may mediate complex signaling interactions that
result in the prevention of DNA damage induced by cigarette smoke.
Table 2. Carotenoid Levels in Plasma and Lung after Supplementation in Various Models.






(2.4¶) 109 ± 21 26.2 ± 1.7 [40]
Lycopene
(1.1#) 226 ± 35 342.2 ± 42.3 [39]
(4.3#) 373 ± 60 1159.2 ± 145 [39]
β-Cryptoxanthin
(7.5**) 69 ± 9 31 ± 5 [54]
(37.5**) 117 ± 20 63 ± 10 [54]
Rat
F344 Lycopene
(20††) 139 ± 41 [106]
Sprague-Dawley β-Carotene
(500‡‡) 0.43 ± 0.03§§ [139]
Mouse
A/J β-Carotene
(120-3000¶¶) 230 ± 60 to
3200 ± 660
340 ± 40 to 3400 ± 380 [71]
Nude mice Lycopene
(20††) 224 ± 51 [106]
BALB/C Lycopene
(20††) 198 ± 52 [106]
*Values are means ± SDs.
†Milligrams per day for 5 to 8 years.
‡Micromoles per liter.
§Milligrams per day for 28 days.
¶Milligrams per kilogram BW for 6 months.
#Milligrams per kilogram BW for 9 weeks.
**Micrograms per kilogram BW for 3 months.
††Milligrams per kilogram BW every 2 days for 10 days.
‡‡Milligrams per kilogram BW for 5 days.
§§Micrograms per gram of tissue.
¶¶Milligram per kilogram feed for 4 weeks.
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Effects of Carotenoids on Levels of RA and RA Signaling
It has been shown that low levels of RA may interfere with retinoid
signal transduction, resulting in an enhancement of cell proliferation
and an increased potential for malignant transformation [120]. In
ferrets, exposure to cigarette smoke and/or high doses of β-carotene
(30 mg/d) was found to induce CYP enzymes in the lungs, to enhance
RA catabolism, and to decrease levels of RARβ [40,121]. However, the
decreased level of RA induced by cigarette smoke exposure and NNK
is restored by β-carotene supplementation in the presence of other anti-
oxidants including α-tocopherol and ascorbic acid [38]. In addition,
oxidative stress induced by high doses of β-carotene (e.g., 2.4 mg/kg
per day, for 6 months) and exposure to cigarette smoke was associated
with increase in levels of AP-1, a complex composed of c-jun and c-fos
[40]. Antiproliferative functions of RA are mediated by RAR/RXR–
dependent repression of AP-1 activity. Moreover, AP-1 sites have been
identified in various genes that are involved in cellular proliferation,
transformation, and death [122]. Correspondingly, it has been hy-
pothesized that lower levels of RA and RARβ down-regulation induced
by cigarette smoke may reduce the inhibitory effects of retinoids on
AP-1. This could then enhance lung cell proliferation and induce the
development of preneoplastic lesions and therefore the potential for
lung carcinogenesis. However, a recent study has demonstrated that
levels of AP-1 were unaffected by various doses of β-carotene in the
presence of DL-α-tocopherol and ascorbyl palmitate in ferrets exposed to
BaP [53]. These contradictory results may be due to differences in the
β-carotene formulations used, and therefore, additional studies need to
be performed. In addition, numerous studies have also reported that RA
prevents abnormal cell proliferation by upregulating mitogen-activated
protein kinase-phosphatase-1 (MKP-1), resulting in dephosphorylation
of mitogen-activated protein kinase [123–125]. Accordingly, levels of
MKP-1 were found to correlate with the concentrations of RA detected
in the lungs of ferrets [126].
Effects of Carotenoids on the Induction of CYP Enzymes
It has been shown that the CYP family of enzymes is activated by
carcinogens present in cigarettes [11,127]. In particular, the induction
of CYP1A1 and CYP1A2 by cigarette smoke enhances RA catabo-
lism and increases levels of carotenoid metabolites, including β-apo-
8′-carotenal. For example, in a comparison of ferrets exposed to cigarette
smoke versus untreated controls, levels of β-apo-8′-carotenal were found
to be three-fold higher in the lung extracts collected from ferrets ex-
posed to cigarette smoke [40,128]. In the study by Gradelet et al.
[128], a nonspecific CYP inhibitor, liaroxole, was used to demonstrate
that P450 enzymes induced by eccentric cleavage breakdown products
of β-carotene are involved in the degradation of RA. On the basis of these
results, it is hypothesized that the induction of CYPs has the capacity to
induce low levels of RA in the lungs of ferrets exposed to cigarette smoke
and/or high doses of β-carotene, thereby providing a possible explana-
tion for the enhanced lung carcinogenesis observed in studies involving
high doses of β-carotene supplementation and smoke exposure. How-
ever, although it has been observed that significant increases in the levels
of several CYP enzymes, including CYP1A1, have been detected in the
lungs of animals supplemented with high doses of β-carotene [121], there
is no sufficient evidence to indicate that carotenoids prevent increases in
CYP enzymes levels in animals with lung cancer.
Figure 1. Possible mechanism(s) of the protective effect of carotenoids on smoke induced lung carcinogenesis. For details, see text.
CYP indicates cytochrome P450; ERK, extracellular signal–regulated kinase; IGF-1, insulin-like growth factor 1; IGFBP-3, IGF binding
protein 3; JNK, c-jun N-terminal kinase; MAPK, mitogen-activated protein kinase; RA, retinoic acid; RAR, retinoic acid receptor; RXR,
retinoid X receptor.
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The carcinogen metabolites of BaP, one of the most important
smoke-derived carcinogens, have the capacity to bind DNA and form
DNA adducts. Salgo et al. [129] has shown that fractions containing
β-carotene metabolites, but not β-carotene itself, were able to facilitate
the binding of carcinogen metabolites present in cigarette smoke to
DNA. Moreover, an induction of BALB/c 3T3 cell transformation
by BaP has been shown to be significantly enhanced in the presence
of β-carotene [130]. However, it is not clear whether the increase in cell
transforming activity associated with β-carotene is due to β-carotene
itself or due to its metabolites. Therefore, these studies indicated that
β-carotene may directly decrease the binding of BaP metabolites to
DNA, whereas β-carotene metabolites from high doses of β-carotene
may facilitate the binding of BaP metabolites to DNA and enhance
lung carcarcinogenesis in smokers.
Effects of Carotenoids on Signaling Pathways Involving in
Apoptosis, Proliferation, and Differentiation
Insulin-like growth factors are mitogens that play an important role
in regulating cell proliferation, differentiation, and apoptosis [131].
IGFBP-3 regulates the bioactivity of IGF-1 by sequestering IGF-1 away
from its receptor, thereby inhibiting the mitogenic activity of IGF-1
[132]. IGF-1 and IGFBP-3 have been implicated in the pathogenesis
of lung cancer, as well as other malignancies, and lung cancer risk is
associated with higher plasma levels of IGF-1 and/or lower levels of
IGFBP-3 [131,133]. In a ferret model, administration of lycopene sup-
plements was associated with an increase in plasma levels of IGFBP-3,
an inhibition of cigarette smoke-induced squamous metaplasia, a de-
crease in proliferating cell nuclear antigen, and a decrease in the phos-
phorylation of BAD [39]. In another model, exposure of ferrets to
cigarette smoke and NNK affected mRNA levels of IGFBP-3 in dif-
ferent tissues. In contrast, a combination of antioxidant supplements
(e.g., β-carotene, α-tocopherol, and ascorbic acid) had no effect on
plasma levels of IGF-1/IGFBP-3 and mRNA expression of IGF-1/
IGFBP-3 in the lung and liver [52]. Additional studies are needed to
further address the mechanisms that mediate tissue-specific expression
of IGF and IGFBP-3.
It has been demonstrated that high doses of β-carotene enhanced
the phosphorylation of JNK and p53, as well as total p53 expression,
induced by cigarette smoke [126]. Moreover, physiological doses of
β-carotene in the presence of α-tocopherol and ascorbic acid have
been shown to block up-regulation of JNK phosphorylation and
p53 phosphorylation at Ser-15 [38]. In contrast, lycopene has been
shown to attenuate elevated levels of p53 induced by cigarette smoke
[39]. In a ferret model, exposure to cigarette smoke has been asso-
ciated with a significant decrease in levels of p21, a promoter of dif-
ferentiation response to cellular stress [41]. Similarly, supplementation
with lycopene has been shown to prevent attenuation of p21, thereby
inhibiting cell growth [39]. Additional study has also demonstrated
that a combination of antioxidants (e.g., β-carotene, α-tocopherol,
and ascorbic acid) play an important role in apoptosis by regulating
Bax levels during lung carcinogenesis [38].
Conclusions
Dietary modifications that delay lung cancer growth have the poten-
tial to reduce morbidity and mortality and decrease medical cost and
treatments. For this reason, appropriate animal studies are required
to investigate the effect of dietary modification on carcinogenesis.
Accordingly, a number of animal models have been developed and
used for lung carcinogenesis studies. However, there remain several
important methodological issues to be solved to study the chemo-
preventive effects of carotenoids in lung carcinogenesis, including
strain-specific and diet-specific effects, and differences in the absorp-
tion and distribution of carotenoids supplemented (e.g., pure lyco-
pene vs pure carotenoids vs carotenoid mixtures vs a combination
with other antioxidants), which may affect the uptake, metabolism,
and storage of carotenoids. Additional factors to consider include
doses, timings of supplementation, and routes of administration in
relation to the induction of carcinogenesis studied [134–136]. Fur-
thermore, the contribution of interactions between carotenoids and
other antioxidants including vitamin C, α-tocopherol, and flavonoids
should be considered. In most animal studies, carotenoid levels in
plasma and tissue are often not described, or the doses of carotenoids
administered are very high. Therefore, it is difficult to interpret the
effects of carotenoids using existing animal models.
Exposure to cigarette smoke is a key factor in studies of high-dose
carotenoid supplementation. Therefore, the dose effects of carotenoids
on lung carcinogenesis in response to smoke exposure in animal models
should be thoroughly examined before large-scale intervention trials
are established, particularly when doses of carotenoids that greatly
exceed normal dietary levels are being considered. It is anticipated that
the development of additional carcinogen-induced or transgenic ani-
mal models will facilitate an elucidation of the mechanisms responsible
for the effects of carotenoids on lung carcinogenesis, leading to im-
provements in prevention and treatment.
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